// App-Quantinova.ai

: Chimeric Antigen Receptor T-Cells for the Treatment of Gamma-Delta T-Cell Malignancies

Researchers

Presenter

  • Paul Maciocia

Principal Investigators

  • Patrycja Wawrzyniecka

  • Leo Kassimatis

  • Martin Pule

Medical Centers

  • Department of Haematological Medicine, King's College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell lymphoma

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Interleukin-2

  • T-cell receptor

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved